Prescription of antidepressants to patients on opioid maintenance therapy - a pharmacoepidemiological study

Norsk Epidemiologi

Volumn 21, Issue 1, 2011, Pages 77-83

  Hartz, Ingeborg ^a   Bramness, Jørgen G ^b,c   Skurtveit, Svetlana ^b,c  

^a INLAND NORWAY UNIVERSITY OF APPLIED SCIENCES   (Norway)

^b UNIVERSITY OF OSLO   (Norway)

^c NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; BUPRENORPHINE; METHADONE; MIANSERIN; MIRTAZAPINE; NALOXONE; NARCOTIC ANALGESIC AGENT; SEROTONIN UPTAKE INHIBITOR; SUBUXONE; TRICYCLIC ANTIDEPRESSANT AGENT; UNCLASSIFIED DRUG;

ADULT; AGE DISTRIBUTION; AGED; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRUG EFFECT; DRUG INDICATION; DRUG INFORMATION; DRUG USE; FEMALE; HUMAN; LONG TERM CARE; MAINTENANCE THERAPY; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PATIENT CARE; PATIENT COMPLIANCE; PHARMACOEPIDEMIOLOGY; PRESCRIPTION; REIMBURSEMENT; TREATMENT DURATION;

EID: 84855799022     PISSN: 08032491     EISSN: None     Source Type: Journal    
DOI: 10.5324/nje.v21i1.1429     Document Type: Article

References (20)

1. Kringlen E, editor. Psykiatri. Oslo: Gyldendal Akademisk, 2001.
2. Wittchen HU, Jacobi F, Rehm J, Gustavsson A, Svensson M, Jonsson B, et al. The size and burden of mental disorders and other disorders of the brain in Europe 2010. Eur Neuropsychopharmacol 2011; 21 (9): 655-79.
3. Landheim AS, Bakken K, Vaglum P. Gender differences in the prevalence of symptom disorders and personality disorders among poly-substance abusers and pure alcoholics. Substance abusers treated in two counties in Norway. Eur Addict Res 2003; 9 (1): 8-17.
4. Lyne JP, O'Donoghue B, Clancy M, O'Gara C. Comorbid psychiatric diagnoses among individuals presenting to an addiction treatment program for alcohol dependence. Subst Use Misuse 2011; 46 (4): 351-8.
5. Peles E, Schreiber S, Naumovsky Y, Adelson M. Depression in methadone maintenance treatment patients: rate and risk factors. J Affect Disord 2007; 99 (1-3): 213-20.
6. Kosten TR, Rounsaville BJ, Kleber HD. A 2.5-year follow-up of depression, life crises, and treatment effects on abstinence among opioid addicts. Arch Gen Psychiatry 1986; 43 (8): 733-8.
7. Rounsaville BJ, Kosten TR, Weissman MM, Kleber HD. Prognostic significance of psychopathology in treated opiate addicts. A 2.5-year follow-up study. Arch Gen Psychiatry 1986; 43 (8): 739-45.
8. Tondo L, Baldessarini RJ, Hennen J, Minnai GP, Salis P, Scamonatti L, et al. Suicide attempts in major affective disorder patients with comorbid substance use disorders. J Clin Psychiatry 1999; 60 Suppl 2: 63-9; discussion 75-6, 113-6.
9. European Monitor Centre for Drugs and Drug Addiction (EMCDDA). 2009 Annual report on the state of the drugs problem in Europe. Available from: http://www.emcdda.europa.eu/publications/annual-report/2009.
10. Waal H, Clausen T, Håseth A, Lillevold P. The 2009 Annual Assessment of the Norwegian OMT-programme. SERAF, Oslo, Norway. Report number 1/2010. Available at: http://www.med.uio.no/klinmed/forskning/sentre/seraf/publikasjoner/rapporter/2010/SERAF-rapport-nr-1-2010-Statusrapport-2009-revidert.pdf.
11. Bramness JG, Hausken AM, Sakshaug S, Skurtveit S, Ronning M. Prescription of selective serotonin reup-take inhibitors 1990-2004. Tidsskr Nor Laegeforen 2005; 125 (18): 2470-3.
12. The Norwegian Prescription Database, National Institute of Public Health. http://www.norpd.no/.
13. Guidelines for ATC classification and DDD assignment. WHO Collaborating Centre for Drug Statistics Methodology, Norwegian Institute of Public Health, Oslo, Norway.
14. Waal H. Merits and problems in high-threshold methadone maintenance treatment. Evaluation of medication-assisted rehabilitation in Norway 1998-2004. Eur Addict Res 2007; 13 (2): 66-73.
15. Norwegian Directorate of Health, 2010. Nasjonal Retningslinje for Legemiddelassistert Rehabilitering ved Opiatavhengighet. Oslo, Norway, IS-1701.
16. Waal H, Clausen T, Haseth A, Lillevold P. The 2008 Annual Assessment of the Norwegian OMT-programme. SERAF, Oslo, Norway. Report number 2/2009.
17. Simpson DD, Joe GW, Rowan-Szal GA. Drug abuse treatment retention and process effects on follow-up outcomes. Drug Alcohol Depend 1997; 47 (3): 227-35.
18. Nunes EV, Sullivan MA, Levin FR. Treatment of depression in patients with opiate dependence. Biol Psychiatry 2004; 56 (10): 793-802.
19. Pani PP, Vacca R, Trogu E, Amato L, Davoli M. Pharmacological treatment for depression during opioid agonist treatment for opioid dependence. Cochrane Database Syst Rev (9): CD008373.
20. Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence: a meta-analysis. JAMA 2004; 291 (15): 1887-96.